Skip to main content
. Author manuscript; available in PMC: 2017 Aug 15.
Published in final edited form as: Head Neck. 2016 Feb 13;38(7):1008–1016. doi: 10.1002/hed.24403

Figure 4.

Figure 4

Analysis of overall survival (OS) and progression free survival (PFS) of HNACC patients in based on CTA expression status: A: OS of NY-ESO-1 positive vs. negative patients, B: PFS of NY-ESO-1 positive vs. negative patients, C: OS of pan-MAGE positive vs. negative patients, D: PFS of pan-MAGE positive vs. negative patients.